Application note: Robust by design – how BD is overcoming the biologics challenge in drug delivery
This application note explores how BD is dedicated to deliver best-in-class product performance and services by applying the latest advances in drug delivery technology.
Becton, Dickinson and Company (BD) is developing a 2.25mL dose volume fully integrated autoinjector with BD Neopak
™ – BD’s latest pre-fillable glass-based syringe system featuring an 8mm needle with ultra-thin wall cannula technology. BD has designed autoinjectors that can deliver drugs of differing viscosities in a well-integrated robust system. Pharmaceutical companies can adapt BD Intevia
™ to deliver a range of drug volumes and viscosities without any need for customisation of the system or its components.